Clinical Research Directory
Browse clinical research sites, groups, and studies.
Quantifying the Burden of Type 2 (T2) Inflammation in Asthma
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
This study is designed to support the assessment of Type 2 (T2) biomarkers in asthma in primary care and community specialty practices. To assess T2 biomarkers, individuals will be required to complete a breath test for fractional exhaled nitric oxide (FeNO) and consent to a review of their medical records. Asthma often goes undetected in primary care and community settings, and through this study the researchers hope to optimize referral pathways to care.
Official title: QUANTAS-PC: Quantifying the Burden of Type 2 (T2) Inflammation in Asthma in Primary Care and Community Specialty Practices
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-07
Completion Date
2027-05
Last Updated
2026-06-30
Healthy Volunteers
No
Conditions
Interventions
FeNO Breath Test
Fractional Exhaled Nitric Oxide (FeNO) test breathing test that measures the amount of nitric oxide in exhaled breath to detect airway inflammation, aiding in the diagnosis and management of asthma
Locations (1)
Mount Sinai Health System
New York, New York, United States